Asunto(s)
COVID-19/genética , Inmunidad Innata/inmunología , SARS-CoV-2/genética , Esteroide Hidroxilasas/genética , COVID-19/inmunología , COVID-19/metabolismo , COVID-19/virología , Regulación Enzimológica de la Expresión Génica , Humanos , Inmunidad Innata/efectos de los fármacos , Metabolismo de los Lípidos/genética , Metabolismo de los Lípidos/inmunología , Lípidos/genética , Lípidos/inmunología , SARS-CoV-2/inmunología , SARS-CoV-2/patogenicidad , Esteroide Hidroxilasas/inmunología , Esteroide Hidroxilasas/metabolismoRESUMEN
Persistent inflammation and extensive immune activation have been associated with HIV-1/SIV pathogenesis. Previously, we reported that cholesterol-25-hydroxylase (CH25H) and its metabolite 25-hydroxycholesterol (25-HC) had a broad antiviral activity in inhibiting Zika, Ebola, and HIV-1 infection. However, the underlying immunological mechanism of CH25H and 25-HC in inhibiting viral infection remains poorly understood. We report here that 25-HC effectively regulates immune responses for controlling viral infection. CH25H expression was interferon-dependent and induced by SIV infection in monkey-derived macrophages and PBMC cells, and 25-HC inhibited SIV infection both in permissive cell lines and primary monkey lymphocytes. 25-HC also strongly inhibited bacterial lipopolysaccharide (LPS)-stimulated inflammation and restricted mitogen-stimulated proliferation in primary monkey lymphocytes. Strikingly, 25-HC promoted SIV-specific IFN-γ-producing cellular responses, but selectively suppressed proinflammatory CD4+ T lymphocytes secreting IL-2 and TNF-α cytokines in vaccinated mice. In addition, 25-HC had no significant immunosuppressive effects on cytotoxic CD8+ T lymphocytes or antibody-producing B lymphocytes. Collectively, 25-HC modulated both innate and adaptive immune responses toward inhibiting HIV/SIV infection. This study provides insights into improving vaccination and immunotherapy regimes against HIV-1 infection.
Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Hidroxicolesteroles/inmunología , Inmunidad Celular , Inmunidad Innata , Macrófagos/inmunología , Síndrome de Inmunodeficiencia Adquirida del Simio/inmunología , Virus de la Inmunodeficiencia de los Simios/inmunología , Animales , Linfocitos T CD4-Positivos/patología , Linfocitos T CD4-Positivos/virología , Línea Celular , Femenino , Macaca , Macrófagos/patología , Macrófagos/virología , Ratones , Ratones Noqueados , Síndrome de Inmunodeficiencia Adquirida del Simio/genética , Síndrome de Inmunodeficiencia Adquirida del Simio/patología , Esteroide Hidroxilasas/genética , Esteroide Hidroxilasas/inmunologíaRESUMEN
Viruses exploit the host and induce drastic metabolic changes to ensure an optimal environment for replication and the production of viral progenies. In response, the host has developed diverse countermeasures to sense and limit these alterations to combat viral infection. One such host mechanism is through interferon signaling. Interferons are cytokines that enhances the transcription of hundreds of interferon-stimulated genes (ISGs) whose products are key players in the innate immune response to viral infection. In addition to their direct targeting of viral components, interferons and ISGs exert profound effects on cellular metabolism. Recent studies have started to illuminate on the specific role of interferon in rewiring cellular metabolism to activate immune cells and limit viral infection. This review reflects on our current understanding of the complex networking that occurs between the virus and host at the interface of cellular metabolism, with a focus on the ISGs in particular, cholesterol-25-hydroxylase (CH25H), spermidine/spermine acetyltransferase 1 (SAT1), indoleamine-2,3-dioxygenase (IDO1) and sterile alpha motif and histidine/aspartic acid domain-containing protein 1 (SAMHD1), which were recently discovered to modulate specific metabolic events and consequently deter viral infection.
Asunto(s)
Inmunidad Innata , Interferones/inmunología , Redes y Vías Metabólicas/inmunología , Transducción de Señal/inmunología , Virosis/inmunología , Acetiltransferasas/inmunología , Animales , Humanos , Indolamina-Pirrol 2,3,-Dioxigenasa/inmunología , Macaca mulatta , Ratones , Proteína 1 que Contiene Dominios SAM y HD/inmunología , Esteroide Hidroxilasas/inmunología , Replicación ViralRESUMEN
A study in mice implicates a cholesterol derivative in damping down the inflammatory response mediated by interleukin-1ß and explaining, at least in part, the immunosuppressive effect of type I interferon, which is used in the treatment of multiple sclerosis.
Asunto(s)
Hidroxicolesteroles/inmunología , Inflamación/inmunología , Interleucina-1beta/antagonistas & inhibidores , Esteroide Hidroxilasas/inmunología , Animales , Hidroxicolesteroles/metabolismo , Inflamación/metabolismo , Interferón Tipo I/inmunología , Deficiencia de Mevalonato Quinasa/inmunología , Deficiencia de Mevalonato Quinasa/metabolismo , Ratones , Ratones Noqueados , Fosfotransferasas (Aceptor de Grupo Alcohol)/genética , Esteroide Hidroxilasas/genéticaRESUMEN
Type I interferon (IFN) protects against viruses, yet it also has a poorly understood suppressive influence on inflammation. Here, we report that activated mouse macrophages lacking the IFN-stimulated gene cholesterol 25-hydroxylase (Ch25h) and that are unable to produce the oxysterol 25-hydroxycholesterol (25-HC) overproduce inflammatory interleukin-1 (IL-1) family cytokines. 25-HC acts by antagonizing sterol response element-binding protein (SREBP) processing to reduce Il1b transcription and to broadly repress IL-1-activating inflammasomes. In accord with these dual actions of 25-HC, Ch25h-deficient mice exhibit increased sensitivity to septic shock, exacerbated experimental autoimmune encephalomyelitis, and a stronger ability to repress bacterial growth. These findings identify an oxysterol, 25-HC, as a critical mediator in the negative-feedback pathway of IFN signaling on IL-1 family cytokine production and inflammasome activity.
Asunto(s)
Hidroxicolesteroles/metabolismo , Inflamación/genética , Interferón Tipo I/inmunología , Esteroide Hidroxilasas/inmunología , Animales , Encefalomielitis Autoinmune Experimental/genética , Encefalomielitis Autoinmune Experimental/inmunología , Retroalimentación Fisiológica , Inflamasomas/genética , Inflamasomas/inmunología , Inflamación/inmunología , Inflamación/microbiología , Interleucina-1/inmunología , Activación de Macrófagos , Macrófagos/inmunología , Ratones , Ratones Endogámicos C57BL , Ratones Mutantes , Elementos de Respuesta/genética , Choque Séptico/genética , Choque Séptico/inmunología , Esteroide Hidroxilasas/genéticaRESUMEN
The active vitamin D metabolite 1α,25-dihydroxyvitamin D (1,25[OH]2 D) potently inhibits DC priming of T-cell activation, suggesting that it mediates a homeostatic role in this context. Therefore, careful regulation of 1,25[OH]2 D levels is necessary to avoid inappropriate inhibition of T-cell activation. Cell-autonomous control of vitamin D activity can be modulated by the action of the vitamin D-activating and -inactivating hydroxylases, CYP27B1, and CYP24A1, respectively. We show that in comparison to macrophages, human monocyte-derived DCs exhibit significantly less activation of 25-dihydroxyvitamin D to 1,25[OH]2 D, and that DCs predominantly express a truncated CYP27B1 transcript that may contribute to the deficiency in activation of vitamin D. Furthermore, in response to stimulation with 1,25[OH]2 D, upregulation of the inactivating enzyme CYP24A1 curtailed the functional effects of vitamin D in DCs, but not macrophages. Production of 1,25[OH]2 D by macrophages was adequate to induce expression of vitamin D-responsive genes by DCs, inhibit DC maturation in response to innate immune stimulation and DC-dependent T-cell responses. Our data suggest that in comparison to macrophages, differential regulation of hydroxylases limits autocrine vitamin D activity in DCs, and that paracrine activation of vitamin D exerts a more potent mechanism for homeostatic control of DC function.
Asunto(s)
25-Hidroxivitamina D3 1-alfa-Hidroxilasa/inmunología , Calcitriol/inmunología , Células Dendríticas/inmunología , Activación de Linfocitos/fisiología , Esteroide Hidroxilasas/inmunología , Linfocitos T/inmunología , Células Dendríticas/citología , Femenino , Homeostasis/fisiología , Humanos , Macrófagos/citología , Macrófagos/inmunología , Masculino , Monocitos/citología , Monocitos/inmunología , Linfocitos T/citología , Vitamina D3 24-HidroxilasaRESUMEN
7α,25-dihydroxycholesterol (7α,25-OHC) is a ligand for the G protein-coupled receptor EBI2; however, the cellular sources of this oxysterol are undefined. 7α,25-OHC is synthesized from cholesterol by the stepwise actions of two enzymes, CH25H and CYP7B1, and is metabolized to a 3-oxo derivative by HSD3B7. We showed that all three enzymes control EBI2 ligand concentration in lymphoid tissues. Lymphoid stromal cells were the main CH25H- and CYP7B1-expressing cells required for positioning of B cells, and they also mediated 7α,25-OHC inactivation. CH25H and CYP7B1 were abundant at the follicle perimeter, whereas CH25H expression by follicular dendritic cells was repressed. CYP7B1, CH25H, and HSD3B7 deficiencies each resulted in defective T cell-dependent plasma cell responses. These findings establish that CYP7B1 and HSD3B7, as well as CH25H, have essential roles in controlling oxysterol production in lymphoid tissues, and they suggest that differential enzyme expression in stromal cell subsets establishes 7α,25-OHC gradients required for B cell responses.
Asunto(s)
Linfocitos B/inmunología , Movimiento Celular/inmunología , Hidroxicolesteroles/inmunología , Inmunidad Humoral/inmunología , Células del Estroma/inmunología , 3-Hidroxiesteroide Deshidrogenasas/genética , 3-Hidroxiesteroide Deshidrogenasas/inmunología , 3-Hidroxiesteroide Deshidrogenasas/metabolismo , Animales , Células de la Médula Ósea/inmunología , Células de la Médula Ósea/metabolismo , Células Cultivadas , Familia 7 del Citocromo P450 , Femenino , Citometría de Flujo , Expresión Génica , Células HEK293 , Humanos , Hidroxicolesteroles/metabolismo , Activación de Linfocitos/inmunología , Tejido Linfoide/inmunología , Tejido Linfoide/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Receptores Acoplados a Proteínas G/genética , Receptores Acoplados a Proteínas G/inmunología , Receptores Acoplados a Proteínas G/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Esteroide Hidroxilasas/genética , Esteroide Hidroxilasas/inmunología , Esteroide Hidroxilasas/metabolismo , Células del Estroma/metabolismoRESUMEN
BACKGROUND: The effects of serum vitamin D status on atopy, steroid requirement, and functional responsiveness to corticosteroids in children versus adults with asthma have not been studied systematically. OBJECTIVE: We sought to explore the age-specific effects of vitamin D in asthmatic patients. METHODS: Serum vitamin D levels were examined in a prospective study of adults and children (102 healthy control subjects and 103 asthmatic patients). PBMCs were cultured for 3 hours with or without 100 nmol/L dexamethasone, and the expression of corticosteroid-regulated genes was detected by using real-time PCR. Serum IgE levels were measured, and information about asthmatic patients' steroid requirements was collected. RESULTS: Deficient serum vitamin D levels (<20 ng/mL) were found in 47.6% of asthmatic patients and 56.8% of healthy control subjects, with means ± SDs of 20.7 ± 9.8 and 19.2 ± 7.7 ng/mL, respectively. In multivariate regression models a significant positive correlation between serum vitamin D levels and the expression of vitamin D-regulated targets, cytochrome P450, family 24, subfamily a (cyp24a) expression by PBMCs (P = .0084, pediatric asthma group only) and serum LL-37 levels (P = .0006 in the pediatric group but P = .0067 in the adult asthma group), was found. An inverse association between vitamin D and serum IgE levels was observed in the pediatric (P = .006) asthma group. Serum vitamin D level (P = .05), as well as PBMC cyp24a expression (P = .0312), demonstrated a significant inverse relationship with daily inhaled corticosteroid dose in the pediatric asthma group only. Cyp24a expression in PBMCs correlated positively with in vitro suppression of TNF-α by dexamethasone (P = .05) and IL-13 (P = .0094) in PBMCs in the pediatric asthma group only. CONCLUSIONS: This study demonstrated significant associations between serum vitamin D status and steroid requirement and in vitro responsiveness to corticosteroids in the pediatric but not the adult asthma group. Vitamin D was also related to IgE levels in children but not in adults.
Asunto(s)
Corticoesteroides/administración & dosificación , Asma/sangre , Asma/tratamiento farmacológico , Asma/inmunología , Vitamina D/sangre , Adolescente , Adulto , Factores de Edad , Células Cultivadas , Niño , Dexametasona/uso terapéutico , Femenino , Humanos , Inmunoglobulina E/sangre , Interleucina-13/genética , Interleucina-13/metabolismo , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/metabolismo , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Esteroide Hidroxilasas/genética , Esteroide Hidroxilasas/inmunología , Esteroide Hidroxilasas/metabolismo , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/metabolismo , Vitamina D3 24-Hidroxilasa , Adulto JovenRESUMEN
The cynomolgus monkey is widely used as a primate model in preclinical studies because of its evolutionary closeness to humans. Despite their importance in drug metabolism, the content of each cytochrome P450 (P450) enzyme has not been systematically determined in cynomolgus monkey livers. In this study, liver microsomes of 27 cynomolgus monkeys were analyzed by immunoblotting using selective P450 antibodies. The specificity of each antibody was confirmed by analyzing the cross-reactivity against 19 CYP1-3 subfamily enzymes using recombinant proteins. CYP2A, CYP2B6, CYP2C9/19, CYP2C76, CYP2D, CYP2E, CYP3A4, and CYP3A5 were detected in all 27 animals. In contrast, CYP1A, CYP1D, and CYP2J were below detectable levels in all liver samples. The average content of each P450 showed that among the P450s analyzed CYP3A (3A4 and 3A5) was the most abundant (40% of total immunoquantified P450), followed by CYP2A (25%), CYP2C (14%), CYP2B6 (13%), CYP2E1 (11%), and CYP2D (3%). No apparent sex differences were found for any P450. Interanimal variations ranged from 2.6-fold (CYP3A) to 11-fold (CYP2C9/19), and most P450s (CYP2A, CYP2D, CYP2E, CYP3A4, and CYP3A5) varied 3- to 4-fold. To examine the correlations of P450 content with enzyme activities, metabolic assays were performed in 27 cynomolgus monkey livers using 7-ethoxyresorufin, coumarin, pentoxyresorufin, flurbiprofen, bufuralol, dextromethorphan, and midazolam. CYP2D and CYP3A4 contents were significantly correlated with typical reactions of human CYP2D (bufuralol 1'-hydroxylation and dextromethorphan O-deethylation) and CYP3A (midazolam 1'-hydroxylation and 4-hydroxylation). The results presented in this study provide useful information for drug metabolism studies using cynomolgus monkeys.
Asunto(s)
Sistema Enzimático del Citocromo P-450/metabolismo , Microsomas Hepáticos/enzimología , Animales , Anticoagulantes/metabolismo , Hidrocarburo de Aril Hidroxilasas/inmunología , Hidrocarburo de Aril Hidroxilasas/metabolismo , Cumarinas/metabolismo , Citocromo P-450 CYP3A/inmunología , Citocromo P-450 CYP3A/metabolismo , Sistema Enzimático del Citocromo P-450/biosíntesis , Sistema Enzimático del Citocromo P-450/genética , Sistema Enzimático del Citocromo P-450/inmunología , Pruebas de Enzimas , Femenino , Humanos , Hidroxilación , Immunoblotting , Inactivación Metabólica , Macaca fascicularis , Masculino , Microsomas Hepáticos/metabolismo , Oxazinas/metabolismo , Sensibilidad y Especificidad , Esteroide Hidroxilasas/inmunología , Esteroide Hidroxilasas/metabolismoRESUMEN
Elevated placental proinflammatory cytokine release is associated with miscarriage, preterm labor and preeclampsia. Specifically, tumor necrosis factor-alpha (TNF-alpha)-induced cytokines may threaten pregnancy outcome. Since trophoblasts produce calcitriol, a hormone with strong immunosuppressive properties, we assessed the effects of this secosteroid on inflammatory cytokines induced in trophoblasts by challenge with TNF-alpha. The effects of calcitriol on synthesis of mRNAs encoding interleukin-6 (IL-6), interferon-gamma (IFN-gamma), and TNF-alpha were measured by real time RT-PCR. Secreted cytokines were quantified by ELISA. The effects of TNF-alpha on CYP24A1, chorionic gonadotropin (hCG), 3beta-hydroxysteroid dehydrogenase (HSD3B1) and P(450)-aromatase (CYP19) mRNA expression were also studied. TNF-alpha stimulated IL-6, IFN-gamma and its own expression more than 3-fold over controls (P<0.05). Calcitriol inhibited the expression profile of inflammatory cytokine genes in a dose-response manner (P<0.05). This effect was prevented by addition of the vitamin D receptor antagonist TEI-9647. TNF-alpha also significantly inhibited expression of hCG, HSD3B1 and CYP19 genes, and stimulated CYP24A1 gene expression. These data show that calcitriol prevents TNF-alpha induction of inflammatory cytokines through a process likely to be mediated by the vitamin D receptor. We conclude that TNF-alpha inhibits placental hormone synthesis and stimulates calcitriol catabolism by regulating enzymes involved in these processes.
Asunto(s)
Calcitriol/inmunología , Hormonas Placentarias/inmunología , Complicaciones del Embarazo/inmunología , Trofoblastos/inmunología , Factor de Necrosis Tumoral alfa/metabolismo , 3-Hidroxiesteroide Deshidrogenasas/antagonistas & inhibidores , 3-Hidroxiesteroide Deshidrogenasas/metabolismo , Aromatasa/genética , Aromatasa/inmunología , Aromatasa/metabolismo , Calcitriol/análogos & derivados , Calcitriol/metabolismo , Calcitriol/farmacología , Células Cultivadas , Gonadotropina Coriónica/genética , Gonadotropina Coriónica/inmunología , Gonadotropina Coriónica/metabolismo , Relación Dosis-Respuesta Inmunológica , Femenino , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Regulación del Desarrollo de la Expresión Génica/inmunología , Humanos , Tolerancia Inmunológica/efectos de los fármacos , Interferón gamma/genética , Interferón gamma/metabolismo , Interleucina-6/genética , Interleucina-6/metabolismo , Embarazo , Progesterona Reductasa/genética , Progesterona Reductasa/inmunología , Progesterona Reductasa/metabolismo , Receptores de Calcitriol/antagonistas & inhibidores , Esteroide Hidroxilasas/genética , Esteroide Hidroxilasas/inmunología , Esteroide Hidroxilasas/metabolismo , Trofoblastos/efectos de los fármacos , Trofoblastos/metabolismo , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/inmunología , Vitamina D3 24-HidroxilasaRESUMEN
Repeated stress led to antipodal directions in immune system and cytochrome P450 activities of normotensive and hypertensive rats. Enhancement of the Reaction of Delayed Hypersensitivity, suppression of cytochrome P450-mediated monooxigenase activities were observed in Wistar rats. On the contrary, in the NISAG decrease of the Reaction Delayed Hypersensitivity, elevation of cytochrome P450-mediated monooxigenase activities were observed, as comparison with Wistar rats.
Asunto(s)
Hipersensibilidad Tardía/inmunología , Hipertensión/inmunología , Oxigenasas de Función Mixta/inmunología , Estrés Fisiológico/inmunología , Animales , Hidrocarburo de Aril Hidroxilasas/inmunología , Hidrocarburo de Aril Hidroxilasas/metabolismo , Citocromo P-450 CYP1A1/inmunología , Citocromo P-450 CYP1A1/metabolismo , Citocromo P-450 CYP2B1/inmunología , Citocromo P-450 CYP2B1/metabolismo , Hipersensibilidad Tardía/enzimología , Hipertensión/enzimología , Oxigenasas de Función Mixta/metabolismo , Ratas , Ratas Wistar , Esteroide Hidroxilasas/inmunología , Esteroide Hidroxilasas/metabolismo , Estrés Fisiológico/enzimologíaRESUMEN
Cholesterol 24-hydroxylase is a cytochrome P450 (CYP46A1) that is selectively expressed in the brain and is responsible for the majority of cholesterol turnover in the central nervous system. Mice deficient in 24-hydroxylase exhibit impaired learning and defective hippocampal long-term potentiation, suggesting that the metabolism of cholesterol by this enzyme is required for learning and memory formation. To determine where in the neuron cholesterol turnover was taking place, monoclonal antibodies directed against 24-hydroxylase were generated by immunization of mice with recombinant protein and used to detect the enzyme in brain homogenates, cultured neurons, and histological sections. 24-Hydroxylase was localized to the endoplasmic reticulum and was distributed throughout the cell bodies and dendrites of multiple types of neurons; the enzyme was not detected in axon terminals or in the cells of 24-hydroxylase knockout mice. 24-Hydroxylase was highly expressed in pyramidal neurons of the hippocampus and cortex, in Purkinje cells of the cerebellum, and in hippocampal and cerebellar interneurons. Within the retina, 24-hydroxylase was detected in ganglion cells and some but not all cells of the inner nuclear layer. These findings reveal the microsomal localization of 24-hydroxylase and provide subcellular insight into cholesterol turnover in the brain.
Asunto(s)
Anticuerpos Monoclonales/inmunología , Especificidad de Anticuerpos/inmunología , Encéfalo/metabolismo , Neuronas/metabolismo , Esteroide Hidroxilasas/metabolismo , Animales , Células Cultivadas , Colesterol 24-Hidroxilasa , Retículo Endoplásmico/metabolismo , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Immunoblotting , Inmunohistoquímica , Ratones , Ratones Endogámicos BALB C , Ratones Noqueados , Ratas , Proteínas Recombinantes/inmunología , Esteroide Hidroxilasas/inmunología , TransfecciónRESUMEN
Vitamin D is produced in the skin by ultraviolet (UV) B radiation (290-320 nm). The active metabolite 1,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] is made systemically by hydroxylation of vitamin D in the liver and the kidney, but also locally in the epidermis, which suggests that 1,25(OH)(2)D(3) may have important functions in the skin. 1,25(OH)(2)D(3) has opposing effects: it can mimic immunosuppressive effects caused by UV irradiation in some models, or reverse UV-induced DNA damage and immunosuppression in other models. 1,25(OH)(2)D(3) exerts effects on Langerhans cells that are characteristic of those associated with UV radiation (UVR)-induced suppression of contact hypersensitivity, and topical application of the vitamin D analogue calcipotriene suppresses contact hypersensitivity in human subjects to a similar extent as UVR. However, 1,25(OH)(2)D(3) decreases DNA damage both in vitro when added to human skin cells in culture before and after UVR, and in vivo when applied to mouse skin after UVR. Furthermore, topical 1,25(OH)(2)D(3) applied to mouse skin after UVR reversed the immunosuppressive effect of UVR in a contact hypersensitivity model. This review will discuss the role of 1,25(OH)(2)D(3) as either a mediator of UVR-induced immune suppression or as a photoprotective molecule against UVR-induced DNA damage and immune suppression.
Asunto(s)
Vitamina D/análogos & derivados , Animales , ADN/efectos de la radiación , Daño del ADN/inmunología , Relación Dosis-Respuesta Inmunológica , Humanos , Tolerancia Inmunológica/efectos de los fármacos , Tolerancia Inmunológica/fisiología , Células de Langerhans/efectos de los fármacos , Células de Langerhans/inmunología , Células de Langerhans/efectos de la radiación , Ratones , Piel/inmunología , Piel/efectos de la radiación , Esteroide Hidroxilasas/efectos adversos , Esteroide Hidroxilasas/inmunología , Vitamina D/farmacología , Vitamina D/fisiologíaRESUMEN
OBJECTIVE: The cytochrome P450 enzyme CYP7B catalyzes the conversion of dehydroepiandrosterone (DHEA) into 7alpha-hydroxy-DHEA (7alpha-OH-DHEA). This metabolite can stimulate the immune response. We previously reported that the severity of murine collagen-induced arthritis is correlated with CYP7B messenger RNA (mRNA) expression and activity in the arthritic joint. The purpose of this study was to investigate the presence of 7alpha-OH-DHEA in synovial samples and the cytokine regulation of CYP7B activity in fibroblast-like synoviocytes (FLS) from patients with rheumatoid arthritis (RA). METHODS: The presence of 7alpha-OH-DHEA was examined in synovial biopsy tissues, synovial fluid, and serum by radioimmunoassay. The effect of cytokines on CYP7B mRNA expression and CYP7B activity in FLS was examined by determining the formation of the CYP7B enzyme product 7alpha-OH-DHEA with the use of high-performance liquid chromatography. RESULTS: The CYP7B enzyme product 7alpha-OH-DHEA was found in synovial biopsy tissues, synovial fluid, and serum from RA patients. The proinflammatory cytokines tumor necrosis factor alpha (TNFalpha), interleukin-1alpha (IL-1alpha), IL-1beta, and IL-17 up-regulated CYP7B activity in an FLS cell line 2-10-fold. Enhanced CYP7B activity was correlated with an increase in CYP7B mRNA. The cytokine transforming growth factor beta inhibited CYP7B activity. Moreover, CYP7B activity was detected in 10 of 13 unstimulated synovial fibroblast cell lines. Stimulation with TNFalpha increased CYP7B activity in all cell lines tested. CONCLUSION: Exposure to the proinflammatory cytokines TNFalpha, IL-1alpha, IL-1beta, and IL-17 increases CYP7B activity in synovial tissue. Increased CYP7B activity leads to higher levels of the DHEA metabolite 7alpha-OH-DHEA in synovial fluid, which may contribute to the maintenance of the chronic inflammation observed in RA patients.
Asunto(s)
Artritis Reumatoide/inmunología , Sistema Enzimático del Citocromo P-450/biosíntesis , Deshidroepiandrosterona/análogos & derivados , Deshidroepiandrosterona/inmunología , Esteroide Hidroxilasas/biosíntesis , Membrana Sinovial/inmunología , Línea Celular , Sistema Enzimático del Citocromo P-450/inmunología , Familia 7 del Citocromo P450 , Citocinas/inmunología , Citocinas/fisiología , Deshidroepiandrosterona/metabolismo , Regulación hacia Abajo , Humanos , Interleucina-1/fisiología , Interleucina-10/fisiología , Esteroide Hidroxilasas/inmunología , Líquido Sinovial/metabolismo , Membrana Sinovial/citología , Factor de Crecimiento Transformador beta/fisiología , Factor de Necrosis Tumoral alfa/fisiología , Regulación hacia ArribaRESUMEN
The cytochrome P4507B1 (P4507B1) is responsible for the 7alpha-hydroxylation of dehydroepiandrosterone (DHEA) and other 3beta-hydroxysteroids in the brain and other organs. The cDNA of human P4507B1 was used for DNA immunization of mice. The best responding mouse led to the production of monoclonal antibodies (mAbs). The clone D16-37 produced an IgM specific for P4507B1 with no cross-reaction with other human P450s. This antibody permitted the immunohistochemical detection of P4507B1 in slices of human hippocampus. P4507B1 was expressed in neurons only. This new tool will be used for the extensive examination of the P4507B1 presence and determination of its levels in slices of human normal and diseased brain and in other human tissues.
Asunto(s)
Anticuerpos Monoclonales/análisis , Sistema Enzimático del Citocromo P-450/análisis , Sistema Enzimático del Citocromo P-450/inmunología , ADN Complementario/administración & dosificación , Esteroide Hidroxilasas/análisis , Esteroide Hidroxilasas/inmunología , Secuencia de Aminoácidos , Animales , Anticuerpos Monoclonales/biosíntesis , Anticuerpos Monoclonales/metabolismo , Especificidad de Anticuerpos , Sitios de Unión de Anticuerpos , Catálisis , Sistema Enzimático del Citocromo P-450/genética , Sistema Enzimático del Citocromo P-450/metabolismo , Familia 7 del Citocromo P450 , ADN Complementario/inmunología , Deshidroepiandrosterona/antagonistas & inhibidores , Deshidroepiandrosterona/metabolismo , Hipocampo/enzimología , Hipocampo/inmunología , Humanos , Inmunoglobulina M/metabolismo , Inmunohistoquímica , Inyecciones Intramusculares , Masculino , Ratones , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Esteroide Hidroxilasas/genética , Esteroide Hidroxilasas/metabolismo , Vacunas de ADN/administración & dosificación , Vacunas de ADN/inmunologíaRESUMEN
Treatment with the immunosuppressive drugs cyclosporin and tacrolimus, the mainstays of anti-graft rejection and autoimmune disease therapy, is limited by their hepato- and nephrotoxicity. The metabolic conversion of these compounds to more easily excretable products is catalysed mainly by hepatic cytochrome P4503A4 (CYP3A4) but also involves extrahepatic CYP3A5 and other P450 forms. We set out to study whether or not exposure to cyclosporin and FK506 in children undergoing organ transplantation leads to formation of autoantibodies against P450s. Immunoblotting analysis revealed anti-CYP reactivity in 16% of children on CyA for anti-graft rejection or treatment of nephrosis (n = 67), 31% of kidney transplant patients switched from CyA to FK506 (n = 16), and 21% of kidney and or liver transplant patients on FK506 (n = 14). In contrast, the frequency of reactive immunoblots was only 8.5% among the normal paediatric controls (n = 25) and 7% among adult kidney transplant patients on CyA or FK506 (n = 30). The CYP2C9+ sera were able to immunoprecipitate in vitro translated CYP2C9 and the immunoblot reactivity showed striking correlation to peaks in the age at onset of drug exposure. Sera were isoform selective as evidenced from Western blotting using human liver microsomes and heterologously expressed human P450s. These findings suggest that anti-cytochrome P450 autoantibodies, identified on the basis of their specific binding in immunoblots, are significantly increased among children on immunosuppressive drugs and in some cases are associated with drug toxicity and organ rejection.
Asunto(s)
Hidrocarburo de Aril Hidroxilasas , Autoanticuerpos/inmunología , Autoantígenos/inmunología , Ciclosporina/efectos adversos , Sistema Enzimático del Citocromo P-450/inmunología , Rechazo de Injerto/inmunología , Inmunoglobulina G/inmunología , Inmunosupresores/efectos adversos , Isoenzimas/inmunología , Esteroide 16-alfa-Hidroxilasa , Tacrolimus/efectos adversos , Adolescente , Adulto , Especificidad de Anticuerpos , Azatioprina/administración & dosificación , Azatioprina/uso terapéutico , Western Blotting , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Enfermedad Hepática Inducida por Sustancias y Drogas/inmunología , Niño , Preescolar , Ciclosporina/administración & dosificación , Ciclosporina/farmacocinética , Ciclosporina/uso terapéutico , Citocromo P-450 CYP1A2/inmunología , Citocromo P-450 CYP2C9 , Citocromo P-450 CYP2E1/inmunología , Citocromo P-450 CYP3A , Quimioterapia Combinada , Epítopos/inmunología , Femenino , Rechazo de Injerto/prevención & control , Humanos , Inmunosupresores/administración & dosificación , Inmunosupresores/farmacocinética , Inmunosupresores/uso terapéutico , Lactante , Enfermedades Renales/inducido químicamente , Enfermedades Renales/inmunología , Trasplante de Riñón/inmunología , Cirrosis Hepática Biliar/inmunología , Trasplante de Hígado/inmunología , Masculino , Persona de Mediana Edad , Oxigenasas de Función Mixta/inmunología , Complicaciones Posoperatorias/inducido químicamente , Prednisona/administración & dosificación , Prednisona/uso terapéutico , Proteínas Recombinantes de Fusión/inmunología , Esteroide Hidroxilasas/inmunología , Tacrolimus/administración & dosificación , Tacrolimus/farmacocinética , Tacrolimus/uso terapéuticoRESUMEN
Hybridomas were isolated that produce 13 monoclonal antibodies (mAbs) that are specific and highly inhibitory to members of the human P450 2C subfamily, 2C8, 2C9, 2C9*2, and 2C19. Many of the mAbs to P450 2C8, 2C9, and 2C19 are specific and exhibit potent inhibitory activity (85-95%). mAb 281-1-1 specifically binds, immunoblots, and strongly inhibits the activity of P450 2C8. mAb 763-15-5 specifically binds and strongly inhibits the activity of P450 2C9. mAb 1-7-4-8 specifically binds and strongly inhibits the activity of P450 2C19. The other mAbs bind and inhibit sets and subsets of the P450 2C family. The single and the combinatorial use of the mAbs can "reaction phenotype", i.e., determine the metabolic contribution and interindividual variation of a P450 isoform for the metabolism of a drug or nondrug xenobiotic in human liver microsomes. The utility of the mAb-based analytic system was examined with the model substrates Taxol (paclitaxel), diazepam, tolbutamide, diclofenac, mephenytoin, and imipramine. The mAb system can identify drugs metabolized by a common P450 or several P450s and polymorphic P450s. The mAb system identifies drugs or drug metabolic pathways that are catalyzed by a single P450 and thus may be used for in vivo phenotyping. The mAb system can identify whether a particular drug is metabolized by a single P450 that may exhibit polymorphic expression in humans. The mAb system offers large potential for studies of cytochrome P450 function useful in drug discovery and reduces the possibility of adverse drug reactions due to polymorphisms and drug interactions.
Asunto(s)
Anticuerpos Monoclonales/farmacología , Especificidad de Anticuerpos , Hidrocarburo de Aril Hidroxilasas , Inhibidores Enzimáticos del Citocromo P-450 , Sistema Enzimático del Citocromo P-450/inmunología , Inhibidores Enzimáticos/farmacología , Oxigenasas de Función Mixta/antagonistas & inhibidores , Oxigenasas de Función Mixta/inmunología , Esteroide 16-alfa-Hidroxilasa , Esteroide Hidroxilasas/antagonistas & inhibidores , Esteroide Hidroxilasas/inmunología , Animales , Anticuerpos Monoclonales/aislamiento & purificación , Anticuerpos Monoclonales/metabolismo , Sitios de Unión de Anticuerpos , Citocromo P-450 CYP2C19 , Sistema Enzimático del Citocromo P-450/metabolismo , Inhibidores Enzimáticos/metabolismo , Humanos , Hibridomas , Ratones , Ratones Endogámicos BALB C , Microsomas Hepáticos/enzimología , Microsomas Hepáticos/inmunología , Microsomas Hepáticos/metabolismo , Oxigenasas de Función Mixta/metabolismo , Esteroide Hidroxilasas/metabolismoRESUMEN
We determined the contribution of cytochrome P450 (CYP) isoforms to the metabolism of midazolam by kinetic analysis of human liver microsomes and CYP isoforms and by examining the effect of chemical inhibitors and monoclonal antibodies against CYP isoforms in vitro. Midazolam was metabolized to 1'-hydroxymidazolam (1'-OH MDZ) by human liver microsomes with a Michaelis-Menten constant (Km) of 4.1 (1.0) (mean (SD)) micromol litre(-1) and a maximum rate of metabolism (Vmax) of 5.5 (1.1) nmol min(-1) mg protein(-1) (n = 6). Of the nine representative human liver CYP isoforms, CYP1A2, 2A6, 2B6, 2C9, 2C19, 2D6, 2E1, 3A4 and 3A5, three (CYP2B6, 3A4 and 3A5) showed midazolam 1'-hydroxylation activity, with Kms of 40.7, 1.7 and 3.0 micromol litre(-1), respectively, and Vmax values of 12.0, 3.3 and 13.2 nmol min(-1) nmol P450(-1), respectively (n = 4). Midazolam 1'-hydroxylation activity of human liver microsomes correlated significantly with testosterone 6beta-hydroxylation activity, a marker of CYP3A activity (r2 = 0.77, P = 0.0001), but not with S-mephenytoin N-demethylation activity, a marker of CYP2B6 activity (r2 < 0.01, P = 0.84) (n = 11). Troleandomycin and orphenadrine, chemical inhibitors of CYP isoforms, inhibited the formation of 1'-OH MDZ by human liver microsomes. Monoclonal antibody against CYP3A4 inhibited the formation of 1'-OH MDZ by 79%, whereas monoclonal antibody against CYP2B6 had no effect on midazolam 1'-hydroxylation by human liver microsomes (n = 5). These results indicate that only CYP3A4, but not CYP2B6 or CYP2C, is involved in the metabolism of midazolam in vitro.
Asunto(s)
Anestésicos Intravenosos/metabolismo , Ansiolíticos/metabolismo , Hidrocarburo de Aril Hidroxilasas , Sistema Enzimático del Citocromo P-450/fisiología , Midazolam/metabolismo , Oxidorreductasas N-Desmetilantes/fisiología , Esteroide 16-alfa-Hidroxilasa , Esteroide Hidroxilasas/fisiología , Anticuerpos Monoclonales/inmunología , Citocromo P-450 CYP1A2 , Citocromo P-450 CYP2B6 , Inhibidores Enzimáticos del Citocromo P-450 , Sistema Enzimático del Citocromo P-450/inmunología , Sistema Enzimático del Citocromo P-450/metabolismo , Inhibidores Enzimáticos/farmacología , Humanos , Hidroxilación , Microsomas Hepáticos/metabolismo , Orfenadrina/farmacología , Oxidorreductasas N-Desmetilantes/antagonistas & inhibidores , Oxidorreductasas N-Desmetilantes/inmunología , Oxidorreductasas N-Desmetilantes/metabolismo , Esteroide Hidroxilasas/antagonistas & inhibidores , Esteroide Hidroxilasas/inmunología , Esteroide Hidroxilasas/metabolismo , Troleandomicina/farmacologíaRESUMEN
Both male and female beagle dogs (four dogs/sex) were orally treated with rifampicin (Rif) at the dose of 10 mg/kg/day for 7 days and an additional eight dogs (four dogs/sex) were used as a control. The inducible effect of Rif on intestinal cytochrome P450, especially CYP3A enzyme, was investigated by measuring microsomal testosterone 6beta-hydroxylation (6beta-OHT) activity, immunoblot and ELISA analysis. In male dogs, microsomal 6beta-OHT activity in the duodenum, upper, middle and lower part of the jejunum and the ileum of the control was 229, 204, 194, 129 and 57 pmol/min/mg protein, while the activity of the Rif-treated dogs significantly increased to 456, 486, 430, 192 and 138 pmol/min/mg protein, respectively. The activity of intestinal 6beta-OHT in the control and Rif-treated female dogs showed almost similar levels to those observed in the corresponding male dogs. The activity of intestinal 6beta-OHT in both control and Rif-treated dogs was specifically inhibited by anti-CYP3A12 antiserum. The apparent K(m) value for 6beta-OHT activity in all sections of the small intestine was comparable with that in the liver, and no significant changes were observed in between control and Rif-treated dogs. In both control and Rif-treated dogs, immunoblotting of intestinal microsomes with anti-CYP3A12 antiserum produced a band indistinguishable from that of purified CYP3A12 or of immunoreactive CYP3A12 in liver microsomes. A significant increase in intestinal CYP3A content by Rif treatment was quantitatively verified by the ELISA analysis and the magnitude of its increase correlated well with that of 6beta-OHT activity elevation. Furthermore, the results of immunohistochemistry using the anti-CYP3A12 antiserum indicated that CYP3A protein was specifically distributed in epithelial cells throughout the small intestine and appeared to be predominant at the apical side of villus cells. These results demonstrate that Rif induces not only hepatic CYP3A12 but also intestinal CYP3A in dogs.
Asunto(s)
Sistema Enzimático del Citocromo P-450/biosíntesis , Intestino Delgado/efectos de los fármacos , Intestino Delgado/enzimología , Rifampin/farmacología , Esteroide Hidroxilasas/biosíntesis , Administración Oral , Animales , Sistema Enzimático del Citocromo P-450/inmunología , Perros , Inducción Enzimática , Ensayo de Inmunoadsorción Enzimática , Femenino , Sueros Inmunes/farmacología , Immunoblotting , Masculino , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/enzimología , Rifampin/administración & dosificación , Esteroide Hidroxilasas/inmunologíaRESUMEN
OBJECTIVE: 27-hydroxycholesterol is the product of the mitochondrial cytochrome P450 sterol 27-hydroxylase, a key enzyme in cholesterol metabolism present in most tissues of the body. 27-hydroxycholesterol increases in abundance with progression of human atherosclerotic lesions, therefore the aim of this study was to determine the pattern of sterol 27-hydroxylase gene expression in normal and diseased arteries and to identify the cell types responsible for its expression. METHODS: Reverse transcription-polymerase chain reaction (RT-PCR) analysis and in situ hybridisation, utilising a sterol 27-hydroxylase cDNA probe, and immunohistochemistry, utilising an antibody to sterol 27-hydroxylase, together with an antibody to smooth muscle cell alpha-actin and an antibody to CD68, a marker for macrophages, were used to study expression of 27-hydroxylase in arterial specimens. In addition, RT-PCR was used to study expression of 27-hydroxylase in cultured macrophages and smooth muscle cells. RESULTS: Semi-quantitative RT-PCR analysis of normal and atherosclerotic human aortas showed that 27-hydroxylase is constitutively expressed in the normal artery wall, and is substantially up-regulated in atherosclerosis. RT-PCR analysis of 27-hydroxylase expression in vitro demonstrated that macrophages constitutively express high levels throughout their differentiation in culture whilst de-differentiated vascular smooth muscle cells express very low levels. In situ hybridisation revealed that in normal artery and fatty streaks, expression of mRNA for 27-hydroxylase was low in the media, but higher in intimal smooth muscle cells. The macrophages of fatty streaks expressed low or undetectable levels of 27-hydroxylase. However in advanced lesions the highest expression of 27-hydroxylase was detectable in macrophages. Immunohistochemistry demonstrated that high levels of 27-hydroxylase protein occurred in macrophages near the shoulder region of plaques, at the edge of the lipid core. CONCLUSIONS: 27-hydroxylase may constitute a protective mechanism for removing cholesterol from macrophages and smooth muscle cells. Genetic heterogeneity resulting in differences in sterol 27-hydroxylase activity between individuals may affect their ability to deal with accumulated cholesterol in the arterial intima, and hence their relative degree of predisposition to atherosclerosis.